Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
IDT Australia Limited (AU:IDT)
ASX:IDT
Holding AU:IDT?
Track your performance easily
IDT Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.07 - AU$0.15
Previous CloseAU$0.12
Volume31.50K
Average Volume (3M)184.65K
Market Cap
AU$48.61M
Enterprise ValueAU$40.27M
Total Cash (Recent Filing)AU$9.21M
Total Debt (Recent Filing)AU$881.00K
Price to Earnings (P/E)―
Beta0.99
Next Earnings
Feb 25, 2025EPS EstimateN/A
Last Dividend Ex-Date
Apr 12, 2010Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares OutstandingN/A
10 Day Avg. Volume104,200
30 Day Avg. Volume184,648
Standard Deviation0.28
R-Squared0.05
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)3.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
IDT Australia Limited News
PremiumCompany Announcements
IDT Australia Sees Revenue Surge Amid Strategic Growth
PremiumCompany Announcements
IDT Australia Announces Hybrid Annual MeetingPremiumCompany Announcements
IDT Australia Announces New Employee Incentive Securities Issue
PremiumCompany Announcements
IDT Australia Grants Shares as Employee Incentives
PremiumCompany Announcements
IDT Australia Presents FY24 Financial Overview
PremiumCompany Announcements
IDT Australia Limited Reports Remarkable Growth
PremiumCompany Announcements
IDT Australia Embraces Corporate Governance Standards
PremiumCompany Announcements
IDT Australia Posts Revenue Surge and Lower LossesOptions Prices
Currently, No data available
---
Ownership Overview
IDT FAQ
What was IDT Australia Limited’s price range in the past 12 months?
IDT Australia Limited lowest share price was AU$0.07 and its highest was AU$0.14 in the past 12 months.
What is IDT Australia Limited’s market cap?
Currently, no data Available
When is IDT Australia Limited’s upcoming earnings report date?
IDT Australia Limited’s upcoming earnings report date is Feb 25, 2025 which is in 107 days.
How were IDT Australia Limited’s earnings last quarter?
IDT Australia Limited released its earnings results on Aug 25, 2024. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
Is IDT Australia Limited overvalued?
According to Wall Street analysts IDT Australia Limited’s price is currently Overvalued.
Does IDT Australia Limited pay dividends?
IDT Australia Limited pays a Annually dividend of <AU$0.01 which represents an annual dividend yield of N/A. See more information on IDT Australia Limited dividends here
What is IDT Australia Limited’s EPS estimate?
IDT Australia Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IDT Australia Limited have?
IDT Australia Limited has 429,841,860 shares outstanding.
What happened to IDT Australia Limited’s price movement after its last earnings report?
IDT Australia Limited reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10%.
Which hedge fund is a major shareholder of IDT Australia Limited?
Currently, no hedge funds are holding shares in AU:IDT
---
IDT Australia Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
53.94%
12-Months-Change
Fundamentals
Return on Equity
-22.75%
Trailing 12-Months
Asset Growth
10.89%
Trailing 12-Months
Company Description
IDT Australia Limited
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services.
---
Technical Analysis
---